These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 33296812

  • 1. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells.
    Wang N, Weng J, Xia J, Zhu Y, Chen Q, Hu D, Zhang X, Sun R, Feng J, Minato N, Gong Y, Su L.
    Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
    [Abstract] [Full Text] [Related]

  • 2. A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells.
    Ma Y, Weng J, Wang N, Zhang Y, Minato N, Su L.
    Int J Biol Macromol; 2021 Jun 01; 180():718-728. PubMed ID: 33753200
    [Abstract] [Full Text] [Related]

  • 3. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
    Zhang Y, Gong Y, Hu D, Zhu P, Wang N, Zhang Q, Wang M, Aldeewan A, Xia H, Qu X, Ring BZ, Minato N, Su L.
    Oncogene; 2015 Mar 12; 34(11):1451-62. PubMed ID: 24704834
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
    Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.
    BMC Cancer; 2009 Sep 18; 9():331. PubMed ID: 19765277
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells.
    Ji K, Ye L, Toms AM, Hargest R, Martin TA, Ruge F, Ji J, Jiang WG.
    Cancer Genomics Proteomics; 2012 Sep 18; 9(5):321-7. PubMed ID: 22990111
    [Abstract] [Full Text] [Related]

  • 7. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
    Ugenskienė R, Myrzaliyeva D, Jankauskaitė R, Gedminaitė J, Jančiauskienė R, Šepetauskienė E, Juozaitytė E.
    Biomarkers; 2016 Sep 18; 21(4):363-70. PubMed ID: 26901824
    [Abstract] [Full Text] [Related]

  • 8. Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
    Pei R, Xu Y, Wei Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y.
    Front Med; 2013 Mar 18; 7(1):138-42. PubMed ID: 23358895
    [Abstract] [Full Text] [Related]

  • 9. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
    Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
    Exp Cell Res; 2017 Mar 15; 352(2):357-363. PubMed ID: 28237246
    [Abstract] [Full Text] [Related]

  • 10. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
    Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P.
    Oncogene; 2010 Mar 04; 29(9):1351-61. PubMed ID: 20010874
    [Abstract] [Full Text] [Related]

  • 11. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
    Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, Freudenheim JL, Ambrosone CB.
    Breast Cancer Res Treat; 2013 Jun 04; 139(3):873-85. PubMed ID: 23771732
    [Abstract] [Full Text] [Related]

  • 12. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
    Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW.
    Nat Genet; 2005 Oct 04; 37(10):1055-62. PubMed ID: 16142231
    [Abstract] [Full Text] [Related]

  • 13. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y, Shimoda M, Hori A, Ohara A, Naoi Y, Ikeda JI, Kagara N, Tanei T, Shimomura A, Shimazu K, Kim SJ, Noguchi S.
    Breast Cancer Res Treat; 2017 Nov 04; 166(1):55-68. PubMed ID: 28702892
    [Abstract] [Full Text] [Related]

  • 14. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.
    Yi SM, Li GY.
    Tumour Biol; 2014 Jan 04; 35(1):441-5. PubMed ID: 24006220
    [Abstract] [Full Text] [Related]

  • 15. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
    Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW.
    Breast Cancer Res; 2006 Jan 04; 8(2):R16. PubMed ID: 16563182
    [Abstract] [Full Text] [Related]

  • 16. Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.
    Li JY, Wang JB, Liu CB, Ma DL, Ma JH.
    Genet Mol Res; 2017 Mar 16; 16(1):. PubMed ID: 28362978
    [Abstract] [Full Text] [Related]

  • 17. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
    Yeh HW, Hsu EC, Lee SS, Lang YD, Lin YC, Chang CY, Lee SY, Gu DL, Shih JH, Ho CM, Chen CF, Chen CT, Tu PH, Cheng CF, Chen RH, Yang RB, Jou YS.
    Nat Cell Biol; 2018 Apr 16; 20(4):479-491. PubMed ID: 29593326
    [Abstract] [Full Text] [Related]

  • 18. 5-Aza-2'-deoxycytidine advances the epithelial-mesenchymal transition of breast cancer cells by demethylating Sipa1 promoter-proximal elements.
    Lu A, Wang W, Wang-Renault SF, Ring BZ, Tanaka Y, Weng J, Su L.
    J Cell Sci; 2020 May 11; 133(9):. PubMed ID: 32193333
    [Abstract] [Full Text] [Related]

  • 19. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
    Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M.
    Int J Cancer; 2009 Apr 01; 124(7):1716-20. PubMed ID: 19089925
    [Abstract] [Full Text] [Related]

  • 20. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
    Yan W, Wen T, Lin S, Liu Z, Yang W, Wu G.
    Zhonghua Zhong Liu Za Zhi; 2015 Oct 01; 37(10):731-5. PubMed ID: 26813590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.